Search research articles
Contact Us
Filters
Showing results (571-580 of 618) with videos related to
Page
of 62
Sort By:
Drug and Alcohol Dependence
|
September 17, 2023
Comprehensive evaluation of the pharmacological and toxicological effects of γ-valerolactone as compared to γ-hydroxybutyric acid: Insights from in vivo and in silico models
Raffaella Arfè, Sabrine Bilel, Micaela Tirri, et al.
Journal of Medicinal Chemistry
|
November 9, 2020
4-(Difluoromethyl)-5-(4-((3<i>R</i>,5<i>S</i>)-3,5-dimethylmorpholino)-6-((<i>R</i>)-3-methylmorpholino)-1,3,5-triazin-2-yl)pyridin-2-amine (PQR626), a Potent, Orally Available, and Brain-Penetrant mTOR Inhibitor for the Treatment of Neurological Disorders
Chiara Borsari, Erhan Keles, Denise Rageot, et al.
Journal of Medicinal Chemistry
|
June 28, 2019
(<i>S</i>)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR Kinase
Denise Rageot, Thomas Bohnacker, Erhan Keles, et al.
Cell
|
December 20, 2024
Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations
Jason J Liu, Beatrice Borsari, Yunyang Li, et al.
Endocrine Connections
|
October 23, 2013
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
Filomena Cetani, Chiara Banti, Elena Pardi, et al.
Epilepsy Research
|
March 11, 2020
The single nucleotide variant n.60G>C in the microRNA-146a associated with susceptibility to drug-resistant epilepsy
Matheus Negri Boschiero, Bruno Camporeze, Jéssica Silva Dos Santos, et al.
European Journal of Medicinal Chemistry
|
September 5, 2025
From pan-active to parasite-selective antiparasitic agents: A scaffold hopping approach
Chiara Borsari, Nuno Santarem, Dina Coertzen, et al.
Journal of General Internal Medicine
|
February 12, 2026
A Cluster Randomized Trial of a Vaccination Communication Educational Intervention: Impact on COVID-19 Vaccine Uptake in Veterans
Karen H Seal, Adam Kaplan, Jennifer K Manuel, et al.
JMIR Mhealth and Uhealth
|
June 16, 2025
College Community-Based Physical Activity Support at a Public University During the COVID-19 Pandemic: Retrospective Longitudinal Analysis of Intra- Versus Interpersonal Components for Uptake and Outcome Association
Garrett I Ash, Selene S Mak, Adrian D Haughton, et al.
Endocrine-Related Cancer
|
December 8, 2020
Gene expression profile in metastatic and non-metastatic parathyroid carcinoma
Vincenzo Condello, Filomena Cetani, Maria Denaro, et al.
Page
of 62
Search research articles
Search
Showing results (571-580 of 618) with videos related to
Sort By:
Page
of 62
Drug and Alcohol Dependence
|
September 17, 2023
Comprehensive evaluation of the pharmacological and toxicological effects of γ-valerolactone as compared to γ-hydroxybutyric acid: Insights from in vivo and in silico models
Raffaella Arfè, Sabrine Bilel, Micaela Tirri, et al.
Journal of Medicinal Chemistry
|
November 9, 2020
4-(Difluoromethyl)-5-(4-((3<i>R</i>,5<i>S</i>)-3,5-dimethylmorpholino)-6-((<i>R</i>)-3-methylmorpholino)-1,3,5-triazin-2-yl)pyridin-2-amine (PQR626), a Potent, Orally Available, and Brain-Penetrant mTOR Inhibitor for the Treatment of Neurological Disorders
Chiara Borsari, Erhan Keles, Denise Rageot, et al.
Journal of Medicinal Chemistry
|
June 28, 2019
(<i>S</i>)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR Kinase
Denise Rageot, Thomas Bohnacker, Erhan Keles, et al.
Cell
|
December 20, 2024
Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations
Jason J Liu, Beatrice Borsari, Yunyang Li, et al.
Endocrine Connections
|
October 23, 2013
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
Filomena Cetani, Chiara Banti, Elena Pardi, et al.
Epilepsy Research
|
March 11, 2020
The single nucleotide variant n.60G>C in the microRNA-146a associated with susceptibility to drug-resistant epilepsy
Matheus Negri Boschiero, Bruno Camporeze, Jéssica Silva Dos Santos, et al.
European Journal of Medicinal Chemistry
|
September 5, 2025
From pan-active to parasite-selective antiparasitic agents: A scaffold hopping approach
Chiara Borsari, Nuno Santarem, Dina Coertzen, et al.
Journal of General Internal Medicine
|
February 12, 2026
A Cluster Randomized Trial of a Vaccination Communication Educational Intervention: Impact on COVID-19 Vaccine Uptake in Veterans
Karen H Seal, Adam Kaplan, Jennifer K Manuel, et al.
JMIR Mhealth and Uhealth
|
June 16, 2025
College Community-Based Physical Activity Support at a Public University During the COVID-19 Pandemic: Retrospective Longitudinal Analysis of Intra- Versus Interpersonal Components for Uptake and Outcome Association
Garrett I Ash, Selene S Mak, Adrian D Haughton, et al.
Endocrine-Related Cancer
|
December 8, 2020
Gene expression profile in metastatic and non-metastatic parathyroid carcinoma
Vincenzo Condello, Filomena Cetani, Maria Denaro, et al.
Page
of 62